Prague 15

• A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women. Ended
  2023-503948-13-00 3 2023-07-20 Healthy Post-menopausal women.
• Randomized, open-label, single dose, two-period, cross-over bioequivalence study comparing test formulation Rosuvastatin/Amlodipine/Ramipril … Ended
  2023-503822-38-00 2 2023-06-19 Not applicable (submitted trial is a bioequivalence study in healthy s
• Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product P … Ended
  2023-504132-18-00 2 2023-06-19 N.A. (submitted trial is a bioequivalence study in healthy human subje
• Single dose, open-label, laboratory blinded, randomised, 2-treatment, 2-period, 2-sequence, crossover bioequivalence study of test product P … Ended
  2023-503345-59-00 2 2023-05-23 Not applicable (submitted trial is a bioequivalence study in Healthy S

Showing 1–4 of 4 trials